Retinal measurements predict 10-year disability in multiple sclerosis.

Autor: Rothman A; Department of Neurology Johns Hopkins University Baltimore Maryland., Murphy OC; Department of Neurology Johns Hopkins University Baltimore Maryland., Fitzgerald KC; Department of Neurology Johns Hopkins University Baltimore Maryland., Button J; Department of Neurology Johns Hopkins University Baltimore Maryland., Gordon-Lipkin E; Department of Neurology Johns Hopkins University Baltimore Maryland., Ratchford JN; Department of Neurology Johns Hopkins University Baltimore Maryland., Newsome SD; Department of Neurology Johns Hopkins University Baltimore Maryland., Mowry EM; Department of Neurology Johns Hopkins University Baltimore Maryland., Sotirchos ES; Department of Neurology Johns Hopkins University Baltimore Maryland., Syc-Mazurek SB; Department of Neurology Johns Hopkins University Baltimore Maryland., Nguyen J; Department of Neurology Johns Hopkins University Baltimore Maryland., Caldito NG; Department of Neurology Johns Hopkins University Baltimore Maryland., Balcer LJ; Department of Neurology New York University Langone Medical Center New York New York., Frohman EM; Department of Neurology and Ophthalmology Dell Medical School University of Texas Austin Austin Texas., Frohman TC; Department of Neurology and Ophthalmology Dell Medical School University of Texas Austin Austin Texas., Reich DS; Department of Neurology Johns Hopkins University Baltimore Maryland.; Translational Neuroradiology Unit National Institutes of Health Bethesda Maryland.; Department of Biostatistics Johns Hopkins University Baltimore Maryland., Crainiceanu C; Department of Biostatistics Johns Hopkins University Baltimore Maryland., Saidha S; Department of Neurology Johns Hopkins University Baltimore Maryland., Calabresi PA; Department of Neurology Johns Hopkins University Baltimore Maryland.
Jazyk: angličtina
Zdroj: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2019 Jan 19; Vol. 6 (2), pp. 222-232. Date of Electronic Publication: 2019 Jan 19 (Print Publication: 2019).
DOI: 10.1002/acn3.674
Abstrakt: Objective: Optical coherence tomography (OCT)-derived measures of the retina correlate with disability and cortical gray matter atrophy in multiple sclerosis (MS); however, whether such measures predict long-term disability is unknown. We evaluated whether a single OCT and visual function assessment predict the disability status 10 years later.
Methods: Between 2006 and 2008, 172 people with MS underwent Stratus time domain-OCT imaging [160 with measurement of total macular volume (TMV)] and high and low-contrast letter acuity (LCLA) testing ( n  = 150; 87%). All participants had Expanded Disability Status Scale (EDSS) assessments at baseline and at 10-year follow-up. We applied generalized linear regression models to assess associations between baseline TMV, peripapillary retinal nerve fiber layer (pRNFL) thickness, and LCLA with 10-year EDSS scores (linear) and with clinically significant EDSS worsening (binary), adjusting for age, sex, optic neuritis history, and baseline disability status.
Results: In multivariable models, lower baseline TMV was associated with higher 10-year EDSS scores (mean increase in EDSS of 0.75 per 1 mm 3 loss in TMV (mean difference = 0.75; 95% CI: 0.11-1.39; P  = 0.02). In analyses using tertiles, individuals in the lowest tertile of baseline TMV had an average 0.86 higher EDSS scores at 10 years (mean difference = 0.86; 95% CI: 0.23-1.48) and had over 3.5-fold increased odds of clinically significant EDSS worsening relative to those in the highest tertile of baseline TMV (OR: 3.58; 95% CI: 1.30-9.82; P trend  = 0.008). pRNFL and LCLA predicted the 10-year EDSS scores only in univariate models.
Interpretation: Lower baseline TMV measured by OCT significantly predicts higher disability at 10 years, even after accounting for baseline disability status.
Competing Interests: A.R., O.C.M., K.F., E.G.L., J.R., E.M., E.S.S., S.B.S.M., J.N., N.G.C., D.R., and C.C has nothing to report. S.D.N. has received consultant fees for scientific advisory boards from Biogen, Genentech, Celgene, EMD Serono and has received research funding from Biogen, Novartis, and Genentech (paid directly to institution). L.J.B. has received consulting fees from Biogen. E.F. has received speaker and consulting fees from Genzyme, Acorda, Novartis, and TEVA. T.F. has received speaker and consulting fees from Acorda, Genzyme, and Novartis. S.S. has received consulting fees from Medical Logix for the development of CME programs in neurology, consulting fees from Axon Advisors LLC and served on scientific advisory boards for Biogen‐Idec, Genzyme, Genentech Corporation & Novartis. He receives research support from Genentech Corporation and Biogen Idec, and received support from the Race to Erase MS foundation. P.A.C. has received personal honorariums for consulting from Biogen and Disarm Therapeutics. He is PI on research grants to Johns Hopkins from MedImmune, Annexon, Biogen, and Genzyme.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje